Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Subsidiary
- Established
- 1997-04-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.cttq.com
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
- Conditions
- Interventions
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 208
- Registration Number
- NCT06211751
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 154
- Registration Number
- NCT06202261
- Locations
- 🇨🇳
Affiliated Cancer Hospital of Chongqing University, Chongqing, Chongqing, China
🇨🇳Affiliated cancer hospital of harbin medical university, Harbin, Heilongjiang, China
A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT06198764
- Locations
- 🇨🇳
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
🇨🇳Zhongshan Hospital Xiamen University, Xiamen, Fujian, China
🇨🇳Xiangya Hospital Central South University, Changsha, Hunan, China
A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT06198751
- Locations
- 🇨🇳
Chongqing Cancer Hospital, Chongqing, Chongqing, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
🇨🇳Fujian Cancer Hospital, Fuzhou, Fujian, China
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
- Conditions
- Interventions
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06165822
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
- First Posted Date
- 2023-12-12
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Registration Number
- NCT06165809
- Locations
- 🇨🇳
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06160895
- Locations
- 🇨🇳
The first hospital of Jilin University, Changchun, Jilin, China
Mass Balance Study of TQB3616
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT06149611
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
- Conditions
- Interventions
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT06150014
- Locations
- 🇨🇳
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University, Chongqing, Chongqing, China
🇨🇳The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi, China
A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06139367
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China